ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021
ACCESSWIRE
06 May 2021, 22:05 GMT+10
ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 /ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2021 on Monday, May 17, 2021 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions. Participation instructions are as follows:
Dial-in Numbers
Replay Passcode: 40908
Webcast
A live audio webcast will be available through the Events & Presentations page of the Investors section of the company s website at www.endrainc.com.
ENDRA Life Sciences Inc.: ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021
Replay Passcode: 40908
Webcast
A live audio webcast will be available through the Events & Presentations page of the Investors section of the company s website at www.endrainc.com.
A replay of the webcast will be available on the website for 60 days.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS
®), a ground-breaking technology that mirrors some applications similar to CT or MRI, but at 50x lower cost and at the point of patient care. TAEUS
® is designed to work in concert with one million ultrasound systems in global use today. TAEUS
ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the Company has recently been issued U.S. Patent
ENDRA Life Sciences Further Strengthens TAEUS(R) System s Intellectual Property Protection with Issuance of Two U.S. Patents
ACCESSWIRE
ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS
®), announces the Company has recently been issued U.S. Patent 10993624 (the ‘624 patent) Systems And Methods For Thermoacoustic Transducer Optimization and U.S. Patent 10996163 (the ‘163 patent) Acoustically Isolated Thermoacoustic Imaging Probe and Process of Manufacture from the United States Patent & Trademark Office (USPTO).
The TAEUS
® transducer serves to receive thermoacoustic ultrasound signals, and the 624 patent provides a tool for developing and adjusting the TAEUS
® probe and its transducer functionality to maximize the amount of information extracted from a subject.
ENDRA Life Sciences Further Strengthens TAEUS(R) System s Intellectual Property Protection with Issuance of Two U S Patents theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.